BACKGROUND: Oral and transdermal postmenopausal hormone replacement therapy (HRT) affects lipid and glucose metabolism differently, which is of significance in the release of leptin by adipocytes. Moreover, oestrogen and progesterone can stimulate leptin secretion in women of reproductive age. Therefore, we compared the effects of oral and transdermal oestrogen plus progestin regimen on plasma leptin in 38 healthy postmenopausal women with normal body mass index (BMI), who wished to use HRT to control incapacitating climacteric symptoms. METHODS: The women were randomized to treatment with oral HRT (2 mg oestradiol on days 1-12, 2 mg oestradiol plus 1 mg norethisterone acetate (NETA) on days 13-22, and 1 mg oestradiol on days 23-28, n ⍧ 19), or with transdermal HRT (50 µg/day of oestradiol on days 1-13, and 50 µg oestradiol plus 250 µg/day NETA on days 14-28, n ⍧ 19) for 1 year. Plasma samples were collected before and at oestradiol ⍣ NETA phase after 2, 6 and 12 months treatment and were assayed for leptin. RESULTS: The baseline leptin, ranging from 3.3 to 34.9 µg/l, was significantly associated with BMI (r ⍧ 0.78, P < 0.0001), but showed no difference between women in oral HRT (geometric mean 13.9 µg/l, 95% confidence interval (CI) 10.1-17.6 µg/l) or transdermal HRT group (geometric mean 12.0 µg/l, 95% CI 9.7-14.3 µg/l). Neither oral nor transdermal oestradiol ⍣ NETA caused any significant changes in plasma leptin (or BMI) after 2, 6, or 12 months of treatment. CONCLUSION: Leptin is an unsuitable factor to detect oestradiol ⍣ NETA-induced metabolic changes in postmenopausal women.
Introduction
Moreover, the use of oestrogen in combination with antiandrogen leads to rises in leptin concentration in transsexual men, Leptin, produced by adipocytes, is a signal to the central but it is not known which component of this combination is nervous system of the adequacy of energy status of the body responsible for the leptin rise (Elbers et al., 1997) . However, (Friedman and Halaas, 1998) . The regulation of the production the overall data on the impact of oestrogen on leptin are and the release of leptin is not completely understood but not uniform, because in one study no difference in leptin lipids, glucose and insulin have been shown to be important concentrations was seen between pre-and postmenopausal determinants of plasma leptin (Boden et al., 1997; Cooling women and the use of contraceptive pills was associated with et Saad et al., 1998) . Oestrogens may also be factors no change in leptin concentrations (Castracane et al., 1998) . in this process (Bray and York, 1997) . Indeed, oestrogens Moreover, natural progesterone can stimulate leptin release stimulate the release of leptin in humans (Casebielli et al., and perhaps accounts for higher concentrations of leptin in the 1998) and in rodents (Shimizu et al., 1997) . Oestrogens may luteal than in the follicular phase of the cycle (Hardie et al., be one of the factors accounting for higher concentrations of 1997; . Progesterone also stimulates leptin in women than in men (Bray and York, 1997; Saad leptin release after ovariectomy, regardless of oestradiol conet al., 1997; Sumner et al., 1998) and also for cyclic elevations centrations (Messinis et al., 2000) . in leptin concentrations during the menstrual cycle (Hardie Conflicting data exist on the effect of oral hormone replaceet al., 1997; . In addition, leptin in ment therapy (HRT) on leptin in postmenopausal women premenopausal women is higher than that in postmenopausal women (Rosenbaum et al., 1996; Shimizu et al., 1997 (comparison with baseline within a single group). Pearson's correlation was used for correlation analyses. A power calculation showed that this population was large enough to detect a 15% change in leptin
Materials and methods
with 87% power at a P-level of 0.05. With the approval of the local ethics committee, we studied 38 nonsmoking postmenopausal women (last menstrual period Ͼ6 months before enrolment, FSH concentrations Ͼ30 IU/l, oestradiol concentraResults tion Ͻ32.7 pg/ml) ( Table I ). These women formed a subgroup of 63
The two study groups were comparable at the start of HRT women, whose vascular reactions to HRT have been reported before regimen (Table I ). Climacteric symptoms were alleviated (Cacciatore et al. 1998) . They had an intact uterus, were otherwise similarly in both groups, and withdrawal bleedings ensued healthy, and used no drugs, but they wished use HRT to control (data not shown). The regimen led to similar rises in plasma incapacitating climacteric symptoms.
Enrolment took place between 1 January and 30 June. The women oestradiol concentrations (Cacciatore et al., 1998) .
were randomized by sealed envelopes to start either oral sequential
Baseline plasma leptin, ranging from 3.3 to 34.9 µg/l, was regimen of HRT (2 mg oestradiol on days 1-12, 2 mg oestradiol plus similar in both groups and was significantly associated with (Table II) . Individual (and insignificant) changes in body Novartis, Basel, Switzerland). The women were seen before the weight and those in plasma leptin at each study point were initiation of HRT and on cycle days 20-22 (combined phase of not related to each other.
oestradiol ϩ NETA) in months 2, 6 and 12 of treatment, when before a routine pelvic examination, a plasma sample was collected between 8 and 10 a.m. for the measurement of leptin. Plasma samples, kept
Discussion
frozen at -80°C, were assayed for leptin by radioimmunoassay (Human leptin RIA kit, Linco Research, Inc., St Louis, MO, USA).
Oestrogen is known to stimulate the synthesis of leptin both in humans (Casebielli et al., 1998) and in rodents (Shimizu et al., 1997) . In addition, the higher leptin levels in women than in men (Bray and York, 1997; Saad et al., 1997; Sumner , , 2000 . We studied the effect conjugated oestrogen plus medroxyprogesterone regimen leptin in women immediately after oophorectomy (Messinis et al., , 2000 . (Kohrt et al., 1996) , similar concentrations of leptin in women with and without HRT (Castracane et al., 1998) Sayegh et al., 1999) .
concentration in women: effect of age, obesity, and estrogen administration.
Our data are in agreement with this opinion, because no the use of oral or transdermal HRT (Table II) .
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